Research question
Is the safety, immunogenicity and effectiveness profile of four doses of wP Hexavalent vaccine (DwPT-HepB-Hib-IPV) given at 6, 10, 14 weeks and 12 to 23 months similar to that of 3 three doses of Pentavalent vaccine (DwPT-HepB-Hib) given at 6, 10, 14 weeks plus 2 doses of IPV at 3 and 9 months?
P: child OR children OR baby OR babies OR infant OR newborn OR neonates OR preschool
I: 4 doses wP Hexavalent vaccine OR DwPT-HepB-Hib-IPV vaccine OR whole cell hexavalent vaccine OR whole-cell vaccine OR 6-in-1 vaccine
C: 3 doses wP Pentavalent vaccine OR DwPT-HepB-Hib vaccine OR whole cell pentavalent vaccine OR whole-cell vaccine OR 5-in-1 vaccine
O: safety OR immunogenicity OR cost effectiveness
A hexavalent vaccine, or 6-in-1 vaccine, is a combination vaccine with six individual vaccines conjugated into one, intended to protect people from multiple diseases. The term usually refers to the children's vaccine that protects against diphtheria, tetanus, pertussis, poliomyelitis, haemophilus B, and hepatitis B, which is used in more than 90 countries around the world.
Shan6® (Shantha Biotechnics/Sanofi Pasteur) – Contains wP along with DTP, Hep B, IPV (inactivated polio vaccine), and Hib.
EasySix® (Panacea Biotec) – Similar composition, used in some countries.